ADC Therapeutics SA (ADCT)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 11:21AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 360.65M |
| Enterprise value | 206.43M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.13 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 2.97 |
| Enterprise value/EBITDA | -1.42 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.74 |
| 52-week change 3 | 89.18% |
| S&P500 52-week change 3 | 21.83% |
| 52-week high 3 | 6.0400 |
| 52-week low 3 | 0.3600 |
| 50-day moving average 3 | 4.5300 |
| 200-day moving average 3 | 2.1107 |
Share statistics
| Avg vol (3-month) 3 | 744.22k |
| Avg vol (10-day) 3 | 516.07k |
| Shares outstanding 5 | 82.53M |
| Implied shares outstanding 6 | 82.91M |
| Float 8 | 62.97M |
| % held by insiders 1 | 29.00% |
| % held by institutions 1 | 41.17% |
| Shares short (28 Mar 2024) 4 | 993.08k |
| Short ratio (28 Mar 2024) 4 | 1.74 |
| Short % of float (28 Mar 2024) 4 | 1.84% |
| Short % of shares outstanding (28 Mar 2024) 4 | 1.20% |
| Shares short (prior month 29 Feb 2024) 4 | 868.84k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -221.69% |
Management effectiveness
| Return on assets (ttm) | -24.54% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 69.56M |
| Revenue per share (ttm) | 0.85 |
| Quarterly revenue growth (yoy) | -75.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -164.8M |
| Net income avi to common (ttm) | -240.05M |
| Diluted EPS (ttm) | -2.9400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 278.6M |
| Total cash per share (mrq) | 3.38 |
| Total debt (mrq) | 427.95M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 4.97 |
| Book value per share (mrq) | -1.80 |
Cash flow statement
| Operating cash flow (ttm) | -118.69M |
| Levered free cash flow (ttm) | -79.93M |
© 2024 Yahoo. All rights reserved.